PANoptosis of Retinal Ganglion Cells

Area of Science:

• Cell Biology
• Neuroscience
• Immunology

Background:

• PANoptosis is a newly identified programmed cell death pathway integrating features of apoptosis, necroptosis, and pyroptosis, regulated by the PANoptosome.
• Retinal ganglion cells (RGCs) are crucial neurons in the central nervous system, and their irreversible loss contributes to diseases like glaucoma and diabetic retinopathy.
• Understanding diverse cell death mechanisms in RGCs is vital for developing therapeutic strategies to prevent vision loss.

Purpose of the Study:

• To provide an overview of PANoptosis, including its fundamental mechanisms and interplay with other cell death pathways.
• To examine the role and characteristics of apoptosis, necroptosis, and pyroptosis in RGC death.
• To investigate the emerging role of PANoptosis in RGCs and its potential as a therapeutic target for preserving RGCs.

Main Methods:

• Literature review and synthesis of existing research on PANoptosis, apoptosis, necroptosis, and pyroptosis.
• Analysis of studies reporting PANoptosis in various disease models, including those affecting RGCs.
• Discussion of the mechanisms and crosstalk between different programmed cell death pathways.

Main Results:

• PANoptosis represents a unified cell death pathway with implications for infectious, inflammatory, neoplastic, and neurodegenerative diseases.
• PANoptosis has recently been identified as a mode of RGC death in experimental models.
• The study highlights the need for further research into PANoptosis in RGCs to understand its pathological role.

Conclusions:

• PANoptosis offers new insights into the pathogenesis of diseases leading to RGC loss.
• Targeting PANoptosis presents a potential novel therapeutic strategy for preventing RGC degeneration and preserving vision.
• Further investigation into PANoptosis mechanisms in neurons is warranted to establish its therapeutic potential.